West Pharmaceutical Services Inc
West Pharmaceutical Services
WST · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $3.1B
- Assets
- $4.3B
- SEC filing
- DEF 14A
- Filed
- March 12, 2026
Executive Compensation
Compensation reported for West Pharmaceutical Services’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Robert W. McMahon
SVP, Chief Financial Officer
$11.8M
Reported total
- Salary
- $0
- Stock awards
- $3,115,000
- Incentives
- $1,765,238
- Option awards
- $5,836,414
- Other
- $1,088,311
Eric M. Green
President and CEO, Chair of Board
$7.2M
Reported total
- Salary
- $1,177,290
- Stock awards
- $3,327,048
- Incentives
- $1,471,613
- Option awards
- $1,108,961
- Other
- $105,964
Shane A. Campbell
SVP, Chief Proprietary Segment Officer
$2.4M
Reported total
- Salary
- $0
- Stock awards
- $100,000
- Incentives
- $629,191
- Option awards
- $1,193,204
- Other
- $480,603
Bernard J. Birkett
Former SVP, Chief Financial Officer
$2.1M
Reported total
- Salary
- $0
- Stock awards
- $0
- Incentives
- $1,004,754
- Option awards
- $1,101,209
- Other
- $37,286
Annette F. Favorite
SVP, Chief Human Resources Officer
$1.4M
Reported total
- Salary
- $450,000
- Stock awards
- $342,875
- Incentives
- $448,590
- Option awards
- $114,191
- Other
- $34,269
Kimberly B. Mac Kay
Former SVP, General Counsel and Secretary
$1.3M
Reported total
- Salary
- $0
- Stock awards
- $0
- Incentives
- $593,067
- Option awards
- $318,188
- Other
- $346,915
Eric M. Green
President and CEO, Chair of Board
$7.2M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 12, 2026.
- Salary
- $1.2M
- Stock Awards
- $3.3M
- Option Awards
- $1.1M
- Incentives
- $1.5M
- Other
- $106K
Historical Compensation
Eric M. Green total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,177,290 | $3,327,048 | $7,190,876 |
| 2024 | $1,170,696 | $3,400,248 | $8,394,201 |
| 2023 | $1,136,654 | $3,250,195 | $9,418,624 |
Named Executive Officers
Eric M. Green
President and CEO, Chair of Board
West Pharmaceutical Services · WST
$7.2M
FY 2025 · DEF 14A
Robert W. McMahon
SVP, Chief Financial Officer
West Pharmaceutical Services · WST
$11.8M
FY 2025 · DEF 14A
Shane A. Campbell
SVP, Chief Proprietary Segment Officer
West Pharmaceutical Services · WST
$2.4M
FY 2025 · DEF 14A
Annette F. Favorite
SVP, Chief Human Resources Officer
West Pharmaceutical Services · WST
$1.4M
FY 2025 · DEF 14A
Kimberly B. Mac Kay
Former SVP, General Counsel and Secretary
West Pharmaceutical Services · WST
$1.3M
FY 2025 · DEF 14A
Bernard J. Birkett
Former SVP, Chief Financial Officer
West Pharmaceutical Services · WST
$2.1M
FY 2025 · DEF 14A
Source information
- Company
- West Pharmaceutical Services Inc
- Ticker
- WST · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 12, 2026
- SEC accession number
- 0001104659-26-026778
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company